Location History:
- Moscow, ID (US) (1998 - 2000)
- Pullman, WA (US) (2016)
Company Filing History:
2 out of 376 
2 out of 2,100 
2 out of 462 
Years Active: 1998-2016
Title: The Innovations of Thomas E. Besser
Introduction
Thomas E. Besser is a notable inventor based in Moscow, Idaho, who has made significant contributions to the field of microbiology and biotechnology. With a total of three patents to his name, Besser's work focuses on innovative solutions to combat pathogenic bacteria and improve health outcomes.
Latest Patents
Among his latest patents is "Microcin and uses thereof - Microcin MccPDI and bacteria harboring the mcpM gene which encodes MccPDI." This invention aims to limit the growth of and/or kill pathogenic bacteria through proximity-dependent inhibition. Another significant patent is related to "Escherichia coli O157:H7 epithelial adhesion and vaccine." This patent involves polypeptides encoded by a continuous segment of chromosomal DNA from E. coli O157:H7, which mediates bacterial colonization of bovine intestines and contributes to vaccine development.
Career Highlights
Throughout his career, Thomas E. Besser has worked with reputable institutions such as Children's Hospital Medical Center and the University of Washington. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Besser has collaborated with esteemed colleagues, including Phillip I. Tarr and Sima S. Bilge, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Thomas E. Besser's innovative work in the field of microbiology demonstrates his commitment to addressing critical health challenges. His patents reflect a dedication to advancing scientific knowledge and improving public health outcomes.